Spots Global Cancer Trial Database for A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia
Official Title: A Multicenter, Open-Label Phase 1b Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Study ID: NCT03625505
Conditions
Study Description
Brief Summary: A dose-escalation study evaluating the safety, tolerability, pharmacokinetics (PK) and efficacy of venetoclax, in combination with gilteritinib, in participants with relapsed or refractory (R/R) acute myeloid leukemia (AML) who have failed to respond to, and/or have relapsed or progressed after at least 1 prior therapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
David Geffen School of Medicin /ID# 200166, Los Angeles, California, United States
UC San Francisco Medical Center-Parnassus /ID# 200205, San Francisco, California, United States
Sylvester Comprehensive Cancer /ID# 200268, Miami, Florida, United States
Northwestern Memorial Hospital /ID# 200230, Chicago, Illinois, United States
Norton Cancer Institute /ID# 200623, Louisville, Kentucky, United States
Johns Hopkins University /ID# 200349, Baltimore, Maryland, United States
Mayo Clinic - Rochester /ID# 200346, Rochester, Minnesota, United States
Hackensack Univ Med Ctr /ID# 200229, Hackensack, New Jersey, United States
Weill Cornell Medical College /ID# 200109, New York, New York, United States
Hosp of the Univ of Penn /ID# 200348, Philadelphia, Pennsylvania, United States
MD Anderson Cancer Center at Texas Medical Center /ID# 206686, Houston, Texas, United States
Contact Details
Name: ABBVIE INC.
Affiliation: AbbVie
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
